The evidence-based British Thoracic Society (BTS) Guideline for pulmonary rehabilitation (PR) in adults was published in 2013.1 There is a strong evidence base for the benefits of PR,2 and it is one ...

The tool kit items created for the 2001 multi-jurisdictional bioterrorism-related anthrax attacks have been undergoing rigorous scientific review at CDC and have informed the response planning ...

We have identified an optimized peptide inhibitor that can be used to develop potent anthrax toxin therapeutics. Anthrax toxin, an essential virulence factor of Bacillus anthracis, elicits many of the ...

Pulmonary hypertension is a rare, ostensibly incurable, and etiologically diverse disease with an unacceptably high 5-year mortality rate (≈50%), worse than many cancers. Irrespective of pathogenic ...

Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity ...

Pulmonary hypertension occurs when there is an abnormally high pressure in the blood vessels between the lungs and the heart.

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by excessive extracellular matrix (ECM) deposition and irreversible lung damage. A key driver of ...

Death from pulmonary embolism isn’t always sudden, but it can be fatal if untreated or in the presence of other health risks. Learn the critical PE signs.